NCT07114354
Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease
Not Yet Recruiting · Not Applicable · The University of Queensland · registry updated 2025-08-11
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
Dementia is observed in 80% of people living with advanced stage Parkinson's disease, however, there are inadequate opportunities for early and effective diagnosis of dementia in current clinical practice. This study aims to identify whether a new tool called PDCogniCare, can improve detection of dementia in people living with Parkinson's disease, and to explore what factors might influence its use in healthcare services.
Inclusion
- People living with idiopathic Parkinson's disease, one year or more post-diagnosis, attending Movement Disorder Clinics
Exclusion
- People with severe Parkinson's disease who aren't able to communicate
- People with comorbid neurological conditions (e.g. Stroke)